Vemurafenib (PLX-4032) is a selective B-Raf kinase inhibitor used in research for malignant melanoma. It is widely applied in both in vitro and in vivo studies to investigate targeted therapies against cancers harboring the BRAF V600E mutation.
Molecular Weight:
489.92
Purity:
99.94% (May vary between batches)
CAS Number:
[1029872-54-5]
Formula:
C23H18ClF2N3O3S
Target:
Raf
Application Notes:
Solubility: DMSO:30 mg/mL (61.23 mM)
* VAT and and shipping costs not included. Errors and price changes excepted